x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- SeroprevalenceRemove Seroprevalence filter
- IgGRemove IgG filter
- 2020 - 2022Remove 2020 - 2022 filter
Author
- Andhalkar, Rushikesh1
- Arunraj, K1
- Asthana, Smita1
- Balachandar, Rakesh1
- Bangar, Sampada Dipak1
- Bansal, Avi Kumar1
- Bharadwaj, Dinesh Kumar1
- Bhargava, Balram1
- Bharti, Pravin1
- Bhat, Jyothi1
- Bhatnagar, Tarun1
- Bhattacharya, Debdutta1
- Chahal, Ashrafjit S1
- Chakrabarti, Amit1
- Chakraborty, Debjit1
- Chaudhury, Anshuman1
- Chopra, Vishal1
- Das, Aparup1
- Das, Dasarathi1
- Dayal, Rakesh1
- Deb, Alok Kumar1
- Deval, Hirawati1
- Devi, Kangjam Rekha1
- Dhaliwal, RS1
- Dhatrak, Sarang1
Coronavirus (COVID-19) Collection
1 Results
- Research ArticleOpen Access
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
International Journal of Infectious DiseasesVol. 108p145–155Published online: May 19, 2021- Manoj V. Murhekar
- Tarun Bhatnagar
- Jeromie Wesley Vivian Thangaraj
- V. Saravanakumar
- Muthusamy Santhosh Kumar
- Sriram Selvaraju
- and others
Cited in Scopus: 56Population-based serosurveys are recommended to estimate the proportion of a population already infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Repeated cross-sectional serosurveys conducted in the same geographical location provide estimates to monitor trends over a period of time (World Health Organization, 2020a). Information from repeated cross-sectional surveys is valuable for public health decision makers to design and revise containment strategies. A meta-analysis undertaken by Chen et al.